Juan Vera Biography and Net Worth

For the past 12 years, Juan F. Vera has worked extensively on developing novel T cell therapies and optimizing manufacturing processes for clinical applications at the Center for Cell and Gene Therapy (CAGT) at Baylor College of Medicine. In collaboration with Wilson Wolf Manufacturing, he has been instrumental in the design and testing of the G-Rex® cell culture platform and pioneered its use for the large-scale production of T cells. Dr. Vera has extensive expertise in developing and streamlining therapeutic candidates from the research bench to the cGMP facility while ensuring robust production and scalability. Dr. Vera has previously collaborated with Celgene and Bluebird Bio in developing novel CAR T cell therapies. He has also been the recipient of different prestigious awards including the Idea Development Award from the Department of Defense and Mentored Research Scholar Award from the American Cancer Society. Dr. Vera attained his M.D. from the University El Bosque in Bogota, Colombia.

What is Juan Vera's net worth?: The estimated net worth of Juan Vera is at least $11.59 million as of March 16th, 2021. Dr. Vera owns 2,564,487 shares of Marker Therapeutics stock worth more than $11,591,481 as of April 24th. This net worth evaluation does not reflect any other assets that Dr. Vera may own. Additionally, Dr. Vera receives an annual salary of $529,120.00 as Insider at Marker Therapeutics. Learn More about Juan Vera's net worth.
How old is Juan Vera?: Dr. Vera is currently 43 years old. There are 1 older executives and no younger executives at Marker Therapeutics. Learn More on Juan Vera's age.
What is Juan Vera's salary?: As the Insider of Marker Therapeutics, Inc., Dr. Vera earns $529,120.00 per year. Learn More on Juan Vera's salary.
How do I contact Juan Vera?: The corporate mailing address for Dr. Vera and other Marker Therapeutics executives is 3200 Southwest Freeway Suite 2240, Houston TX, 77027. Marker Therapeutics can also be reached via phone at (713) 400-6400 and via email at [email protected]. Learn More on Juan Vera's contact information.
Has Juan Vera been buying or selling shares of Marker Therapeutics?: Juan Vera has not been actively trading shares of Marker Therapeutics during the last ninety days. Most recently, on Tuesday, March 16th, Juan Vera bought 571,428 shares of Marker Therapeutics stock. The stock was acquired at an average cost of $1.75 per share, with a total value of $999,999.00. Following the completion of the transaction, the insider now directly owns 2,564,487 shares of the company's stock, valued at $4,487,852.25. Learn More on Juan Vera's trading history.

Juan Vera Insider Trading History at Marker Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/16/2021	Buy	571,428	$1.75	$999,999.00	2,564,487

Juan Vera Buying and Selling Activity at Marker Therapeutics

Marker Therapeutics Company Overview

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells. The company also develops MT-401-OTS, which is in phase 1 clinical trial for the treatment of acute myeloid leukemia; and MT-601 which is in phase 1 clinical trial for the treatment of lymphoma, as well as in phase 1/2 clinical trial for the treatment of pancreatic cancer. Marker Therapeutics is headquartered in Houston, Texas.

Today's Range

Now: $4.40

$4.36

$4.59

50 Day Range

MA: $4.27

$3.63

$4.91

2 Week Range

Now: $4.40

$0.76

$9.68

Volume

9,980 shs

Average Volume

20,635 shs

Market Capitalization

$39.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Exposed: 10 CENT Crypto to Explode April 20th?

From True Market Insiders | Ad

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024